FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to new reproductive technologies in obstetrics. It involves immune-enzyme analysis of a biological fluid. In women with induced pregnancy, the follicular fluid is analysed for specific immunocomplexes, namely alpha 2-macroglobulin-immunoglobulin G (MG-IgG) and lactoferrin immunoglobulin G (LF-IgG), and if MG-IgG is less than 0.6 mcg/ml, and LF-IgG is less than 0.8 mcg/ml, high probability of early miscarriage is predicted.
EFFECT: method allows developing a method for prediction of early miscarriage that allows for well-timed administration of high-level luteal phase support immediately after oocyte sampling and without waiting for IVF program termination.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF EF AND ET PROGRAMS | 2015 |
|
RU2581027C1 |
METHOD OF ASSESSMENT OF READINESS OF FEMALES WITH CHRONIC ENDOMETRITIS TO EXTRACORPOREAL FERTILIZATION | 2015 |
|
RU2617061C1 |
METHOD FOR PREDICTION OF SPONTANEOUS MISCARRIAGE | 2013 |
|
RU2529788C1 |
METHOD FOR PREDICTING THE EFFICIENCY OF IVF PROGRAMS WITH TUBE-PERITONEAL INFERTILITY ASSOCIATED WITH CHRONIC ENDOMETRY | 2017 |
|
RU2677467C1 |
PREDICTION METHOD OF OUTCOMES OF INFERTILITY TREATMENT BY EXTRACORPORAL IMPREGNATION METHOD | 2007 |
|
RU2357673C1 |
METHOD FOR PREDICTION OF PREGNANCY IN IN VITRO FERTILIZATION | 2016 |
|
RU2648839C1 |
METHOD FOR PREDICTION OF POSTOPERATIVE FERTILITY RECOVERY IN FEMALES WITH ENDOMETRIOSIS GENITALIS EXTERNA | 2013 |
|
RU2523556C1 |
METHOD FOR PREDICTING THE DEGREE OF RISK OF NEGATIVE RESULTS OF IN VITRO FERTILIZATION | 2021 |
|
RU2773798C1 |
ANTIGEN-SPECIFIC METHOD FOR DETECTING IMMUNE PROTEIN COMPLEXES OF MACROGLOBULINS GROUP WITH IMMUNOGLOBULIN G IN BIOLOGICAL LIQUIDS | 2002 |
|
RU2209435C1 |
METHOD OF PREDICTING RESULT OF EXTRACORPORAL FERTILISATION AND EMBRYO TRANSFER (ECF AND ET) | 2011 |
|
RU2476142C1 |
Authors
Dates
2010-07-20—Published
2009-04-14—Filed